Corcept Therapeutics | Lånekapital



Loan Capital Endring Dato
Acadia Pharmaceuticals USD 0 0 2024-12
Alaunos Therapeutics USD 0 0 2024-09
ANI Pharmaceuticals USD 614.92M 302M 2024-12
Ardelyx USD 150.85M 50.15M 2024-12
Aurora Cannabis CAD 41.68M 542K 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
J&J USD 30.65B 638M 2024-12
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Merck USD 34.46B 520M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pacira USD 383.54M 2.35M 2024-12
Pfizer USD 57.4B 597M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
TG Therapeutics USD 244.43M 271K 2024-12



Corcept Therapeutics Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.